| The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis K Dheda, T Gumbo, G Maartens, KE Dooley, R McNerney, M Murray, ... The lancet Respiratory medicine 5 (4), 291-360, 2017 | 537 | 2017 |
| Feasibility, accuracy, and clinical effect of point-of-care Xpert MTB/RIF testing for tuberculosis in primary-care settings in Africa: a multicentre, randomised, controlled trial G Theron, L Zijenah, D Chanda, P Clowes, A Rachow, M Lesosky, W Bara, ... The Lancet 383 (9915), 424-435, 2014 | 481 | 2014 |
| Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting G Theron, J Peter, R van Zyl-Smit, H Mishra, E Streicher, S Murray, ... American journal of respiratory and critical care medicine 184 (1), 132-40, 2011 | 369 | 2011 |
| Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis K Dheda, T Gumbo, NR Gandhi, M Murray, G Theron, Z Udwadia, ... The lancet Respiratory medicine 2 (4), 321-338, 2014 | 298 | 2014 |
| Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic … JG Peter, LS Zijenah, D Chanda, P Clowes, M Lesosky, P Gina, N Mehta, ... The Lancet 387 (10024), 1187-1197, 2016 | 233 | 2016 |
| What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa? A Pooran, E Pieterson, M Davids, G Theron, K Dheda PloS one 8 (1), e54587, 2013 | 209 | 2013 |
| Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study VB Patel, G Theron, L Lenders, B Matinyena, C Connolly, R Singh, ... PLoS medicine 10 (10), e1001536, 2013 | 199 | 2013 |
| The South African tuberculosis care cascade: estimated losses and methodological challenges P Naidoo, G Theron, MX Rangaka, VN Chihota, L Vaughan, ZO Brey, ... The Journal of infectious diseases 216 (suppl_7), S702-S713, 2017 | 190 | 2017 |
| Do high rates of empirical treatment undermine the potential effect of new diagnostic tests for tuberculosis in high-burden settings? G Theron, J Peter, D Dowdy, I Langley, SB Squire, K Dheda The Lancet infectious diseases 14 (6), 527-532, 2014 | 167 | 2014 |
| Point‐of‐care diagnosis of tuberculosis: Past, present and future K Dheda, M Ruhwald, G Theron, J Peter, WC Yam Respirology 18 (2), 217-232, 2013 | 165 | 2013 |
| Diagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients JG Peter, G Theron, R van Zyl-Smit, A Haripersad, L Mottay, S Kraus, ... European respiratory journal 40 (5), 1211-1220, 2012 | 161 | 2012 |
| The diagnostic accuracy of the GenoTypeŽ MTBDRsl assay for the detection of resistance to second-line anti-tuberculosis drugs G Theron, J Peter, M Richardson, M Barnard, S Donegan, R Warren, ... The Cochrane database of systematic reviews, 4, 2014 | 130 | 2014 |
| Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-discharged patients with programmatically incurable … K Dheda, JD Limberis, E Pietersen, J Phelan, A Esmail, M Lesosky, ... The lancet Respiratory medicine 5 (4), 269-281, 2017 | 124 | 2017 |
| Xpert MTB/RIF results in patients with previous tuberculosis: can we distinguish true from false positive results? G Theron, R Venter, G Calligaro, L Smith, J Limberis, R Meldau, ... Clinical Infectious Diseases 62 (8), 995-1001, 2016 | 124 | 2016 |
| Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid G Theron, J Peter, R Meldau, H Khalfey, P Gina, B Matinyena, L Lenders, ... Thorax 68 (11), 1043-1051, 2013 | 118 | 2013 |
| Determinants of PCR performance (Xpert MTB/RIF), including bacterial load and inhibition, for TB diagnosis using specimens from different body compartments G Theron, J Peter, G Calligaro, R Meldau, C Hanrahan, H Khalfey, ... Scientific reports 4 (1), 1-10, 2014 | 116 | 2014 |
| Data for action: collection and use of local data to end tuberculosis G Theron, HE Jenkins, F Cobelens, I Abubakar, AJ Khan, T Cohen, ... The Lancet 386 (10010), 2324-2333, 2015 | 113 | 2015 |
| Drug-associated adverse events and their relationship with outcomes in patients receiving treatment for extensively drug-resistant tuberculosis in South Africa K Shean, E Streicher, E Pieterson, G Symons, R van Zyl Smit, G Theron, ... PloS one 8 (5), e63057, 2013 | 108 | 2013 |
| The Diagnostic Accuracy of Urine-Based Xpert MTB/RIF in HIV-Infected Hospitalized Patients Who Are Smear-Negative or Sputum Scarce JG Peter, G Theron, TE Muchinga, U Govender, K Dheda PLoS ONE 7 (7), e39966, 2012 | 104 | 2012 |
| Comparison of quantitative techniques including Xpert MTB/RIF to evaluate mycobacterial burden RN van Zyl-Smit, A Binder, R Meldau, H Mishra, PL Semple, G Theron, ... PloS one 6 (12), e28815, 2011 | 101 | 2011 |
Jonathan PeterUniversity of Cape TownVerified email at uct.ac.za
